111 (YI) Other Non Operating Income (2017 - 2025)

111's (YI) quarterly Other Non Operating Income came in at $27000.0 in Q4 2025, up 120.77% year-on-year from $12230.0 in Q4 2024, and up 8.0% quarter-over-quarter from $25000.0 in Q3 2025.

111 (YI) Other Non Operating Income (2017 - 2025) Analysis & Trends

111 has disclosed Other Non Operating Income across 9 years of filings, most recently posting $27000.0 for Q4 2025.

  • Other Non Operating Income for Q4 2025 came in at $27000.0, up 120.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $67000.0 (up 154.92% YoY), and the FY2025 annual result was $69000.0, up 155.2% from the prior year.
  • Other Non Operating Income came in at $27000.0 for Q4 2025 at 111, up from $25000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $257000.0 in Q4 2022 to a low of -$737000.0 in Q2 2022.
  • The 5-year median for Other Non Operating Income is $10000.0 (2023), against an average of -$39200.0.
  • Across the five-year window, Other Non Operating Income jumped 4925.0% in 2021 and sank 1020.31% in 2022, its largest moves.
  • 111's Other Non Operating Income stood at $245000.0 in 2021, then climbed by 4.9% to $257000.0 in 2022, then declined by 6.61% to $240000.0 in 2023, then sank by 154.17% to -$130000.0 in 2024, then jumped by 120.77% to $27000.0 in 2025.
  • The last three Other Non Operating Income figures came in at $27000.0 (Q4 2025), $25000.0 (Q3 2025), and $9000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn
10 Cellyan Biotechnology 5.69 -2.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 27,000.00
Sep 30, 2025 25,000.00
Jun 30, 2025 9,000.00
Mar 31, 2025 6,000.00
Dec 31, 2024 -130,000.00
Sep 30, 2024 91,000.00
Jun 30, 2024 -53,000.00
Mar 31, 2024 -30,000.00
Dec 31, 2023 240,000.00
Sep 30, 2023 11,000.00
Jun 30, 2023 -387,000.00
Mar 31, 2023 238,000.00
Dec 31, 2022 257,000.00
Sep 30, 2022 -717,000.00
Jun 30, 2022 -737,000.00
Mar 31, 2022 62,000.00
Dec 31, 2021 245,000.00
Sep 30, 2021 -64,000.00
Jun 30, 2021 201,000.00
Mar 31, 2021 -78,000.00